Table of Content

1. Executive Summary
1.1. Global Postoperative Pain Management Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Global Postoperative Pain Management Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025–2032
4.3. Global Postoperative Pain Management Market Outlook: Drug
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Drug, 2019 – 2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025 – 2032
4.3.3.1. Opioids
4.3.3.1.1. Tramadol
4.3.3.1.2. Oxycodone
4.3.3.1.3. Hydrocodone
4.3.3.1.4. Other Opioids
4.3.3.2. NSAIDs
4.3.3.3. Local Anesthetics
4.3.3.4. Acetaminophen
4.3.4. Market Attractiveness Analysis: Drug
4.4. Global Postoperative Pain Management Market Outlook: Route of Administration
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019 – 2023
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 – 2032
4.4.3.1. Injectable
4.4.3.2. Oral
4.4.3.3. Rectal
4.4.3.4. Topical
4.4.3.5. Transdermal
4.4.3.6. Others
4.4.4. Market Attractiveness Analysis: Route of Administration
4.5. Global Postoperative Pain Management Market Outlook: Prescription Type
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Prescription Type, 2019 – 2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025 – 2032
4.5.3.1. Over-The-Counter (OTC) Products
4.5.3.2. Prescription Drugs
4.5.4. Market Attractiveness Analysis: Prescription Type
4.6. Global Postoperative Pain Management Market Outlook: Distribution Channel
4.6.1. Introduction / Key Findings
4.6.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 – 2023
4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
4.6.3.1. Hospital Pharmacies
4.6.3.2. Specialty Clinics
4.6.3.3. Long Term Care Centers
4.6.3.4. Retail Pharmacies
4.6.3.5. Drug Stores
4.6.3.6. Online Pharmacies
4.6.4. Market Attractiveness Analysis: Distribution Channel
5. Global Postoperative Pain Management Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 – 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 – 2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Postoperative Pain Management Market Outlook
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
6.2.1. By Country
6.2.2. By Drug
6.2.3. By Route of Administration
6.2.4. By Prescription Type
6.2.5. By Distribution Channel
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025 – 2032
6.4.1. Opioids
6.4.1.1. Tramadol
6.4.1.2. Oxycodone
6.4.1.3. Hydrocodone
6.4.1.4. Other Opioids
6.4.2. NSAIDs
6.4.3. Local Anesthetics
6.4.4. Acetaminophen
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 – 2032
6.5.1. Injectable
6.5.2. Oral
6.5.3. Rectal
6.5.4. Topical
6.5.5. Transdermal
6.5.6. Others
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025 – 2032
6.6.1. Over-The-Counter (OTC) Products
6.6.2. Prescription Drugs
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
6.7.1. Hospital Pharmacies
6.7.2. Specialty Clinics
6.7.3. Long Term Care Centers
6.7.4. Retail Pharmacies
6.7.5. Drug Stores
6.7.6. Online Pharmacies
6.8. Market Attractiveness Analysis
7. Europe Postoperative Pain Management Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
7.2.1. By Country
7.2.2. By Drug
7.2.3. By Route of Administration
7.2.4. By Prescription Type
7.2.5. By Distribution Channel
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025 – 2032
7.4.1. Opioids
7.4.1.1. Tramadol
7.4.1.2. Oxycodone
7.4.1.3. Hydrocodone
7.4.1.4. Other Opioids
7.4.2. NSAIDs
7.4.3. Local Anesthetics
7.4.4. Acetaminophen
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 – 2032
7.5.1. Injectable
7.5.2. Oral
7.5.3. Rectal
7.5.4. Topical
7.5.5. Transdermal
7.5.6. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025 – 2032
7.6.1. Over-The-Counter (OTC) Products
7.6.2. Prescription Drugs
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
7.7.1. Hospital Pharmacies
7.7.2. Specialty Clinics
7.7.3. Long Term Care Centers
7.7.4. Retail Pharmacies
7.7.5. Drug Stores
7.7.6. Online Pharmacies
7.8. Market Attractiveness Analysis
8. East Asia Postoperative Pain Management Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
8.2.1. By Country
8.2.2. By Drug
8.2.3. By Route of Administration
8.2.4. By Prescription Type
8.2.5. By Distribution Channel
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025 – 2032
8.4.1. Opioids
8.4.1.1. Tramadol
8.4.1.2. Oxycodone
8.4.1.3. Hydrocodone
8.4.1.4. Other Opioids
8.4.2. NSAIDs
8.4.3. Local Anesthetics
8.4.4. Acetaminophen
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 – 2032
8.5.1. Injectable
8.5.2. Oral
8.5.3. Rectal
8.5.4. Topical
8.5.5. Transdermal
8.5.6. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025 – 2032
8.6.1. Over-The-Counter (OTC) Products
8.6.2. Prescription Drugs
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
8.7.1. Hospital Pharmacies
8.7.2. Specialty Clinics
8.7.3. Long Term Care Centers
8.7.4. Retail Pharmacies
8.7.5. Drug Stores
8.7.6. Online Pharmacies
8.8. Market Attractiveness Analysis
9. South Asia & Oceania Postoperative Pain Management Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
9.2.1. By Country
9.2.2. By Drug
9.2.3. By Route of Administration
9.2.4. By Prescription Type
9.2.5. By Distribution Channel
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025 – 2032
9.4.1. Opioids
9.4.1.1. Tramadol
9.4.1.2. Oxycodone
9.4.1.3. Hydrocodone
9.4.1.4. Other Opioids
9.4.2. NSAIDs
9.4.3. Local Anesthetics
9.4.4. Acetaminophen
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 – 2032
9.5.1. Injectable
9.5.2. Oral
9.5.3. Rectal
9.5.4. Topical
9.5.5. Transdermal
9.5.6. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025 – 2032
9.6.1. Over-The-Counter (OTC) Products
9.6.2. Prescription Drugs
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
9.7.1. Hospital Pharmacies
9.7.2. Specialty Clinics
9.7.3. Long Term Care Centers
9.7.4. Retail Pharmacies
9.7.5. Drug Stores
9.7.6. Online Pharmacies
9.8. Market Attractiveness Analysis
10. Latin America Postoperative Pain Management Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
10.2.1. By Country
10.2.2. By Drug
10.2.3. By Route of Administration
10.2.4. By Prescription Type
10.2.5. By Distribution Channel
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025 – 2032
10.4.1. Opioids
10.4.1.1. Tramadol
10.4.1.2. Oxycodone
10.4.1.3. Hydrocodone
10.4.1.4. Other Opioids
10.4.2. NSAIDs
10.4.3. Local Anesthetics
10.4.4. Acetaminophen
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 – 2032
10.5.1. Injectable
10.5.2. Oral
10.5.3. Rectal
10.5.4. Topical
10.5.5. Transdermal
10.5.6. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025 – 2032
10.6.1. Over-The-Counter (OTC) Products
10.6.2. Prescription Drugs
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
10.7.1. Hospital Pharmacies
10.7.2. Specialty Clinics
10.7.3. Long Term Care Centers
10.7.4. Retail Pharmacies
10.7.5. Drug Stores
10.7.6. Online Pharmacies
10.8. Market Attractiveness Analysis
11. Middle East & Africa Postoperative Pain Management Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
11.2.1. By Country
11.2.2. By Drug
11.2.3. By Route of Administration
11.2.4. By Prescription Type
11.2.5. By Distribution Channel
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025 – 2032
11.4.1. Opioids
11.4.1.1. Tramadol
11.4.1.2. Oxycodone
11.4.1.3. Hydrocodone
11.4.1.4. Other Opioids
11.4.2. NSAIDs
11.4.3. Local Anesthetics
11.4.4. Acetaminophen
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 – 2032
11.5.1. Injectable
11.5.2. Oral
11.5.3. Rectal
11.5.4. Topical
11.5.5. Transdermal
11.5.6. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025 – 2032
11.6.1. Over-The-Counter (OTC) Products
11.6.2. Prescription Drugs
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
11.7.1. Hospital Pharmacies
11.7.2. Specialty Clinics
11.7.3. Long Term Care Centers
11.7.4. Retail Pharmacies
11.7.5. Drug Stores
11.7.6. Online Pharmacies
11.8. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.3.1. Teva Pharmaceutical Industries Ltd
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Novartis AG
12.3.3. Allergan plc
12.3.4. GlaxoSmithKline plc
12.3.5. Mylan N.V.
12.3.6. Johnson & Johnson
12.3.7. Pfizer Inc.
12.3.8. Purdue Pharma L.P
12.3.9. Janssen Pharmaceuticals, Inc
12.3.10. Endo International plc
12.3.11. Baxter International
12.3.12. Pacira Pharmaceuticals Inc.
12.3.13. Cadila Healthcare Limited
12.3.14. Cipla Limited
12.3.15. Eisan
12.3.16. LG Chem
12.3.17. AbbVie Inc.
12.3.18. Amgen Inc.
12.3.19. Sun Pharmaceutical Ltd.
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations